Gestational diabetes in a tertiary care hospital: implications of applying the IADPSG criteria.
Arch Gynecol Obstet
; 286(2): 373-8, 2012 Aug.
Article
en En
| MEDLINE
| ID: mdl-22484479
ABSTRACT
BACKGROUND:
The American Diabetes Association has endorsed the International Association of Diabetes and Pregnancy Groups (IADPSG) recommendation that every pregnant woman should undergo the 75 g oral glucose tolerance test (OGTT) to screen for gestational diabetes mellitus (GDM).PURPOSE:
To find the cost and workload implications of switching from the current two-step screening of GDM to the one-step IADPSG approach.METHODS:
The cost (US $) and laboratory workload units (WLU) were calculated for three possible strategies (1) 50 g glucose screen, if positive, followed by the 100 g OGTT; (2) universal 75 g OGTT; and (3) screening with the initial fasting plasma glucose of the OGTT.RESULTS:
For the 1,101 pregnant women screened in 1 year, the cost of the three strategies was $ 31,985, $ 55,250 and $ 35,875, respectively; the laboratory burden was 28,975 WLU, 18,662 WLU and 12,215 WLU, respectively.CONCLUSIONS:
Switching to the one-step, strategy 2 (IADPSG) would increase the cost by 42 % but decrease the laboratory workload by 36 % compared to the two-step, strategy 1. However, an initial screen by the fasting plasma glucose of the OGTT is the ideal strategy, both in terms of cost and laboratory workload.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Diabetes Gestacional
/
Centros de Atención Terciaria
/
Prueba de Tolerancia a la Glucosa
Tipo de estudio:
Prognostic_studies
/
Screening_studies
Límite:
Adolescent
/
Adult
/
Female
/
Humans
/
Middle aged
/
Pregnancy
Idioma:
En
Revista:
Arch Gynecol Obstet
Asunto de la revista:
GINECOLOGIA
/
OBSTETRICIA
Año:
2012
Tipo del documento:
Article
País de afiliación:
Emiratos Árabes Unidos